Trial Profile
A Phase II Study of Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Pyrotinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 29 Jan 2018 New trial record